BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 29/02/2012

FDA Withdraws Hearing Requests for Hydroxyzine Hydrochloride and Hydroxyzine Pamoate Prescription Drugs

The FDA has withdrawn all outstanding hearing requests for prescription drugs containing hydroxyzine hydrochloride or hydroxyzine pamoate, making it unlawful to ship these products in interstate commerce after a specified date

Source: Federal Register — Food and Drug AdministrationOpen original release →